Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Baroldi Joseph sold 5,635 Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 26, 2026 · Filed Jun 30, 2026
On Jun 26, 2026, Baroldi Joseph (EVP, Chief Business Officer) sold 5,635 Ionis Pharmaceuticals, Inc. shares at US$80.16 for US$452K under a trading plan, leaving 4,669 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 5,635 shares
- Price
- US$80.16
- Value
- US$452K
- Holding after
- 4,669 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 3,866 | US$56.78 | 8,535 | Indirect |
| Jun 26, 2026 | Common Stock | Option exercise | 1,769 | US$32.60 | 10,304 | Indirect |
| Jun 26, 2026 | Common Stock | Sale | 5,635 | US$80.16 | 4,669 | Indirect |
Source
Related
- Ionis Pharmaceuticals, Inc.
- Baroldi Joseph
- Ionis Pharmaceuticals, Inc. shareholders
- Form 4 · Baroldi Joseph · Apr 30, 2026
- Form 4 · Baroldi Joseph · Apr 17, 2026
- Form 4 · Devers Shannon L. · Oct 19, 2026
- Form 4 · Swayze Eric · Oct 19, 2026
- Form 4 · Bennett C Frank · Sep 2, 2026
- Form 4 · O'Neil Patrick R. · Sep 2, 2026
- Form 4 · Monia Brett P · Sep 2, 2026